Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with acute or chronic wounds, including surgical site infections and trauma-related injuries. Individuals with no known allergies to copper-based compounds or plasma-derived products. Wounds classified as mild to moderate in severity, without extensive necrosis or gangrene.
Exclusion criteria
Exclusion criteria: Patients with severe wound infections, extensive necrosis, or gangrene. Individuals with known allergies to copper-based compounds or plasma-derived products. Patients with underlying conditions that may interfere with wound healing, such as uncontrolled diabetes or immunodeficiency disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of antimicrobial activity of copper nanoparticles,accelerated wound healing,biocompatibility of the productTimepoint: Efficacy of antimicrobial activity of copper nanoparticles,accelerated wound healing,biocompatibility of the product assessed at 4,8 and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical relevance of the formulation by investigating its safety, cytotoxicity, & effectiveness in promoting tissue regeneration & infection control. Timepoint: Assessed at 12 weeks | — |
Countries
India
Contacts
Saveetha medical College and hospital